Business Combinations (Tables)

9 Months Ended

Sep. 30, 2021

Summary of Revenue and Operating Income or Loss

Revenue and operating income or loss from both acquisitions since the respective 2021 acquisition dates are included in the accompanying Condensed Consolidated Statements of Operations as follows, in thousands:

	Net Sales		Operating Income (loss)
FF Gene Biotech	$	4,556	$	(1,612	)
CSI		7,101		659
Total	$	11,657	$	(953	)

FF Gene Biotech

Business Acquisition [Line Items]

Summary of Consideration Paid and Amount of Assets Acquired and Liabilities Assumed

The following table summarizes the consideration paid and the amounts of the assets acquired and liabilities assumed recognized at the FF Gene Biotech Acquisition date, as well as the fair value of the noncontrolling interest at the FF Gene Biotech Acquisition date.

	Amounts
	(in thousands)
Considerations
Cash	$	18,974
Fair value of the Company’s 30% equity interest held before the business combination		3,734
	$	22,708
Recognized amounts of identifiable assets acquired and liabilities assumed
Financial assets	$	3,181
Reagents and supplies		1,288
Fixed assets		3,874
Other tangible assets		944
Identifiable intangible assets		6,958
Other current liabilities		(2,585	)
Notes payable		(5,893	)
Recognized amounts of identifiable assets acquired and liabilities assumed, net		7,767
Noncontrolling interest		(8,141	)
Goodwill		23,082
Total	$	22,708

Cytometry Specialists, Inc

Business Acquisition [Line Items]

Summary of Consideration Paid and Amount of Assets Acquired and Liabilities Assumed

The following tables summarizes the consideration paid and the amounts of the assets acquired and liabilities assumed recognized at the CSI Acquisition date:

	Amounts
	(in thousands)
Considerations
Cash	$	43,359
Contingent consideration		8,500
	$	51,859
Recognized amounts of identifiable assets acquired and liabilities assumed
Debt-free net working capital	$	4,270
Fixed assets		6,855
ROU assets - operating		4,988
ROU assets - finance		49
Other assets		160
Identifiable intangible assets		30,540
Deferred tax liability		(9,629	)
Operating lease liabilities		(4,988	)
Finance lease liabilities		(49	)
Other liabilities		(6,069	)
Recognized amounts of identifiable assets acquired and liabilities assumed, net		26,127
Goodwill		25,732
Total	$	51,859